Literature DB >> 23504559

PD-1 gene polymorphism in children with subacute sclerosing panencephalitis.

Ibrahim Etem Piskin1, Mustafa Calık, Mahmut Abuhandan, Ebru Kolsal, Sevim Karakas Celik, Akın Iscan.   

Abstract

Subacute sclerosing panencephalitis (SSPE) is a progressive inflammatory and degenerative disorder of the central nervous system. Several factors influence the risk of chronic brain infection with the mutant measles virus. However, to date, no pathogenic mechanism that may predispose to SSPE has been determined. Studies have indicated that specific polymorphisms in certain host genes are probably involved in impairing the ability of host immune cells to eradicate the measles virus in SSPE patients. Programmed cell death protein 1 (PD-1), a member of the CD28 family, is a negative regulator of the immune system. The purpose of our study was to investigate whether PD-1 gene polymorphisms affect susceptibility to the development of SSPE in Turkish children. In total, 109 subjects (54 SSPE patients and 55 healthy controls) were genotyped for the PD-1.9 C/T (rs2227982) single-nucleotide polymorphism (SNP). The distributions of T alleles in the PD-1.9 polymorphism in SSPE patients and healthy controls were 2.8 and 10.9%, respectively. There was a statistically significant difference between the groups; the 95% confidence interval (CI) was 0.06 to 0.85 and the odds ratio (OR) was 0.23 (χ(2) test). Thus, we identified an association between SSPE and the PD-1 rs2227982 gene polymorphism; the frequency of T alleles was higher in controls than in SSPE patients. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23504559     DOI: 10.1055/s-0033-1338134

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  4 in total

1.  Association of PD-1 and PDL-1 gene polymorphisms with colorectal cancer risk and prognosis.

Authors:  Mehtap Cevik; Esat Namal; Ulkuhan Iner-Koksal; Nur Dinc-Sener; Atila Karaalp; Cavlan Ciftci; Belgin Susleyici
Journal:  Mol Biol Rep       Date:  2022-01-25       Impact factor: 2.316

2.  Subacute sclerosing panencephalitis in a toddler: changing epidemiological trends.

Authors:  Roosy Aulakh; Abhimanyu Tiwari
Journal:  Case Rep Pediatr       Date:  2013-12-12

Review 3.  Advances in Antiviral Therapy for Subacute Sclerosing Panencephalitis.

Authors:  Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

Review 4.  Subacute sclerosing panencephalitis in pregnancy.

Authors:  Michael H Chiu; Bonnie Meatherall; Ana Nikolic; Kristine Cannon; Kevin Fonseca; Jeffrey T Joseph; Judy MacDonald; Kanti Pabbaraju; Raymond Tellier; Sallene Wong; Marcus W Koch
Journal:  Lancet Infect Dis       Date:  2016-01-20       Impact factor: 25.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.